Higher Vitamin B6 Status is Associated with Improved Survival Among Patients with Stage I-III Colorectal Cancer

Background: Folate-mediated 1-carbon metabolism requires several nutrients, including vitamin B6. Circulating biomarker concentrations indicating high vitamin B6 status are associated with a reduced risk of colorectal cancer (CRC). However, little is known about the effect of B6 status in relation to clinical outcomes in CRC patients.

Objectives: We investigated survival outcomes in relation to vitamin B6 status in prospectively followed CRC patients.

Methods: A total of 2031 patients with stage I-III CRC participated in 6 prospective patient cohorts in the international FOCUS (folate-dependent 1-carbon metabolism in colorectal cancer recurrence and survival) Consortium. Preoperative blood samples were used to measure vitamin B6 status by the direct marker pyridoxal 5'-phosphate (PLP), as well as the functional marker HK-ratio (HKr)[3'-hydroxykynurenine: (kynurenic acid + xanthurenic acid + 3'-hydroxy anthranilic acid + anthranilic acid)]. Using Cox proportional hazards regression, we examined associations of vitamin B6 status with overall survival (OS), disease-free survival (DFS), and risk of recurrence, adjusted for patient age, sex, circulating creatinine concentrations, tumor site, stage, and cohort.

Results: After a median follow-up of 3.2 y for OS, higher preoperative vitamin B6 status as assessed by PLP and the functional marker HKr was associated with 16-32% higher all-cause and disease-free survival, although there was no significant association with disease recurrence (doubling in PLP concentration: HROS, 0.68; 95% CI: 0.59, 0.79; HRDFS, 0.84; 95% CI: 0.75, 0.94; HRRecurrence, 0.96; 95% CI: 0.84, 1.09; HKr: HROS, 2.04; 95% CI: 1.67, 2.49; HRDFS, 1.56; 95% CI: 1.31, 1.85; HRRecurrence, 1.21; 95% CI: 0.96,1. 52). The association of PLP with improved OS was consistent across colorectal tumor site (right-sided colon: HROS, 0.75; 95% CI: 0.59, 0.96; left-sided colon: HROS, 0.71; 95% CI: 0.55, 0.92; rectosigmoid junction and rectum: HROS, 0.61; 95% CI: 0.47, 0.78).

Conclusion: Higher preoperative vitamin B6 status is associated with improved OS among stage I-III CRC patients.

Citing Articles

Recent Advances on the Role of B Vitamins in Cancer Prevention and Progression.

Frost Z, Bakhit S, Amaefuna C, Powers R, Ramana K Int J Mol Sci. 2025; 26(5).

PMID: 40076592 PMC: 11900642. DOI: 10.3390/ijms26051967.

Serum Pyridoxal 5'-Phosphate and Pyridoxic Acid Ratio Index with Prognosis of Colorectal Cancer: A Prospective Cohort Study.

Li X, Xu L, Ou Q, Xu H, Chen Y, Fang Y Nutrients. 2024; 16(21).

PMID: 39519518 PMC: 11547691. DOI: 10.3390/nu16213685.

Vitamin B6 deficiency cooperates with oncogenic Ras to induce malignant tumors in Drosophila.

Pilesi E, Tesoriere G, Ferriero A, Mascolo E, Liguori F, Argiro L Cell Death Dis. 2024; 15(6):388.

PMID: 38830901 PMC: 11148137. DOI: 10.1038/s41419-024-06787-3.

Role of dietary nutrients and metabolism in colorectal cancer.

Ye J, Bao X, Wei J, Zhang Y, Liu Y, Xin L Asia Pac J Clin Nutr. 2024; 33(2):153-161.

PMID: 38794975 PMC: 11170022. DOI: 10.6133/apjcn.202406_33(2).0002.

Relationship of Low Vitamin B6 Status with Sarcopenia, Frailty, and Mortality: A Narrative Review.

Kato N, Kimoto A, Zhang P, Bumrungkit C, Karunaratne S, Yanaka N Nutrients. 2024; 16(1).

PMID: 38202006 PMC: 10780671. DOI: 10.3390/nu16010177.

References

Paul L, Ueland P, Selhub J . Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation. Nutr Rev. 2013; 71(4):239-44. DOI: 10.1111/nure.12014. View

Geijsen A, Ulvik A, Gigic B, Kok D, van Duijnhoven F, Holowatyj A . Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI Cancer Spectr. 2020; 4(5):pkaa051. PMC: 7583160. DOI: 10.1093/jncics/pkaa051. View

Kiblawi R, Holowatyj A, Gigic B, Brezina S, Geijsen A, Ose J . One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study. Br J Nutr. 2020; 123(10):1187-1200. PMC: 7425811. DOI: 10.1017/S0007114520000422. View

Ulvik A, Midttun O, Pedersen E, Eussen S, Nygard O, Ueland P . Evidence for increased catabolism of vitamin B-6 during systemic inflammation. Am J Clin Nutr. 2014; 100(1):250-5. DOI: 10.3945/ajcn.114.083196. View

Subar A, Krebs-Smith S, Cook A, Kahle L . Dietary sources of nutrients among US adults, 1989 to 1991. J Am Diet Assoc. 1998; 98(5):537-47. DOI: 10.1016/S0002-8223(98)00122-9. View

Ulrich C, Gigic B, Bohm J, Ose J, Viskochil R, Schneider M . The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes. Cancer Epidemiol Biomarkers Prev. 2018; 28(3):591-601. PMC: 6420345. DOI: 10.1158/1055-9965.EPI-18-0773. View

Galluzzi L, Vacchelli E, Michels J, Garcia P, Kepp O, Senovilla L . Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene. 2013; 32(42):4995-5004. DOI: 10.1038/onc.2012.623. View

Ishihara J, Otani T, Inoue M, Iwasaki M, Sasazuki S, Tsugane S . Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr. 2007; 137(7):1808-14. DOI: 10.1093/jn/137.7.1808. View

Zhu Y, Wu H, Wang P, Savas S, Woodrow J, Wish T . Dietary patterns and colorectal cancer recurrence and survival: a cohort study. BMJ Open. 2013; 3(2). PMC: 3586110. DOI: 10.1136/bmjopen-2012-002270. View

10.

Zhang S, Moore S, Lin J, Cook N, Manson J, Lee I . Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2005; 163(2):108-15. PMC: 1363749. DOI: 10.1093/aje/kwj016. View

11.

Yang W, Liu S, Li Y, Wang Y, Deng Y, Sun W . Pyridoxine induces monocyte-macrophages death as specific treatment of acute myeloid leukemia. Cancer Lett. 2020; 492:96-105. DOI: 10.1016/j.canlet.2020.08.018. View

12.

Ueland P, Ulvik A, Rios-Avila L, Midttun O, Gregory J . Direct and Functional Biomarkers of Vitamin B6 Status. Annu Rev Nutr. 2015; 35:33-70. PMC: 5988249. DOI: 10.1146/annurev-nutr-071714-034330. View

13.

Figueiredo J, Levine A, Grau M, Midttun O, Ueland P, Ahnen D . Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):2136-45. PMC: 2518404. DOI: 10.1158/1055-9965.EPI-07-2895. View

14.

Schernhammer E, Ogino S, Fuchs C . Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology. 2008; 135(3):770-80. PMC: 2634965. DOI: 10.1053/j.gastro.2008.06.033. View

15.

Gylling B, Myte R, Schneede J, Hallmans G, Haggstrom J, Johansson I . Vitamin B-6 and colorectal cancer risk: a prospective population-based study using 3 distinct plasma markers of vitamin B-6 status. Am J Clin Nutr. 2017; 105(4):897-904. DOI: 10.3945/ajcn.116.139337. View

16.

de Vogel S, Schneede J, Ueland P, Vollset S, Meyer K, Fredriksen A . Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2011; 20(8):1726-35. DOI: 10.1158/1055-9965.EPI-11-0359. View

17.

Midttun O, Ulvik A, Pedersen E, Ebbing M, Bleie O, Schartum-Hansen H . Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J Nutr. 2011; 141(4):611-7. DOI: 10.3945/jn.110.133082. View

18.

Lee J, Li H, Giovannucci E, Lee I, Selhub J, Stampfer M . Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev. 2009; 18(4):1197-202. PMC: 2755048. DOI: 10.1158/1055-9965.EPI-08-1001. View

19.

Galluzzi L, Kepp O, Vander Heiden M, Kroemer G . Metabolic targets for cancer therapy. Nat Rev Drug Discov. 2013; 12(11):829-46. DOI: 10.1038/nrd4145. View

20.

Le Marchand L, White K, Nomura A, Wilkens L, Selhub J, Tiirikainen M . Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2009; 18(8):2195-201. PMC: 2978659. DOI: 10.1158/1055-9965.EPI-09-0141. View